Login with your work email address to view charts. No credit card required.
| Art Unit: | 1612 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 504 — Plant protecting and regulating compositions 554 — Organic compounds -- part of the class 532-570 series 521 — Synthetic resins or natural rubbers -- part of the class 520 series 426 — Food or edible material: processes, compositions, and products 222 — Dispensing |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr Gen Chem |
| Service: | 20 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 64% over 434 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 68th
|
With Examiner Maewall, you have a 64% chance of getting an issued patent by 3 years after the first office action. Examiner Maewall is a harder examiner and in the 68th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Maewall, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Maewall's grant rate is higher than that of Art Unit 1612 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Maewall | 2.0 |
| Art Unit 1612 | 1.9 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.